Upgrade to SI Premium - Free Trial

Larimar Therapeutics (LRMR)

2.42 -0.02 (0.82%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Form 4 Larimar Therapeutics, For: Sep 29 Filed by: Harlow John B. Jr. October 1, 2026 4:27 PM - SEC Filing Form 3 Larimar Therapeutics, For: Sep 29 Filed by: Harlow John B. Jr. October 1, 2026 4:27 PM - SEC Filing Form 8-K Larimar Therapeutics, For: Sep 29 September 29, 2026 4:07 PM - SEC Filing Larimar Therapeutics names John Harlow as president and COO September 29, 2026 4:05 PM - StreetInsider Larimar Therapeutics Strengthens Executive Leadership with Appointment of John Harlow as President and Chief Operating Officer September 29, 2026 4:05 PM - Globe NewsWire Leerink Starts Larimar Therapeutics (LRMR) at Outperform September 14, 2026 6:06 AM - StreetInsider Century Therapeutics names Joseph Truitt to its board of directors September 9, 2026 4:05 PM - StreetInsider Century Therapeutics Appoints Joseph Truitt to Board of Directors September 9, 2026 4:05 PM - StreetInsider Larimar Therapeutics, Inc. (LRMR) Tops Q2 EPS by 8c August 4, 2026 7:24 AM - StreetInsider Form 10-Q Larimar Therapeutics, For: Jun 30 August 4, 2026 7:12 AM - SEC Filing Form 8-K Larimar Therapeutics, For: Aug 04 August 4, 2026 7:03 AM - SEC Filing Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update August 4, 2026 7:00 AM - Globe NewsWire Full Article List